Abstract: A Retrospective Analysis to Assess the Effect of Targeted Clinical Interventions on the Discontinuation Rate of Amikacin Liposome Inhalation Suspension Therapy among Patients Treated for Refractory Mycobacterium Avium Complex Lung Disease